AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

25 recruiting trials

for Refractory Lupus Nephritis

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD19- BCMA CAR-T cells NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis NCT06676631Phase 11 site๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital ยท Tests: NK 010 or NK042, Rituximab A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis NCT07570862Phase 212 sites๐Ÿ“ Beverly Hills๐Ÿ“ Fontana๐Ÿ“ Fullerton Fate Therapeutics ยท Tests: FT819 CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis NCT06785519EARLY Phase 11 site๐Ÿ“ Hangzhou He Huang ยท Tests: CD19/BCMA Lupus Nephritis Targeted CAR T-cells injection Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497361EARLY Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: PRG-2311 A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases NCT07115745Phase 128 sites๐Ÿ“ Boston๐Ÿ“ Durham๐Ÿ“ Camperdown Juno Therapeutics, Inc., a Bristol-Myers Squibb Company ยท Tests: BMS-986515, Fludarabine, Cyclophosphamide, Tocilizumab A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis NCT07328581Phase 24 sites๐Ÿ“ Chicago๐Ÿ“ Hawthorne๐Ÿ“ New Hyde Park iCell Gene Therapeutics ยท Tests: ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following lymphodepletion CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH NCT06947460Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: CD19-BCMA CAR-T cells infusion SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus NCT07523542Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-โ€ฆ Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE) NCT06902844NA1 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Equecabtagene Autoleucel Injection A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease NCT06925542Phase 117 sites๐Ÿ“ La Jolla๐Ÿ“ Redwood City๐Ÿ“ Chicago CRISPR Therapeutics ยท Tests: CTX112 A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE NCT06897930Phase 1, Phase 220 sites๐Ÿ“ San Francisco๐Ÿ“ Stanford๐Ÿ“ Tampa AstraZeneca ยท Tests: AZD0120, Cyclophosphamide, Fludarabine UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis NCT07109986Phase 11 site๐Ÿ“ Nanjing Nanjing IASO Biotechnology Co., Ltd. ยท Tests: UB-VV410 Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. NCT06947473Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: umbilical cord blood CD19-BCMA CAR-T cells infusion Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497387EARLY Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: PRG-1801 Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN) NCT07053800Phase 215 sites๐Ÿ“ New York๐Ÿ“ Syracuse๐Ÿ“ San Antonio Autolus Limited ยท Tests: Obecabtagene autoleucel Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells NCT06277427NA1 site๐Ÿ“ Wuhan Lingli Dong ยท Tests: PRG-1801 ๏ผˆCAR-T against BCMA๏ผ‰ A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases NCT07123519Phase 11 site๐Ÿ“ Tianjin China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07236762Phase 11 site๐Ÿ“ Bengbu China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell US Zamto-cel Autoimmune Diseases NCT06708845Phase 11 site๐Ÿ“ Milwaukee Miltenyi Biomedicine GmbH ยท Tests: zamtocabtagene autoleucel, Cyclophosphamide, Fludarabine Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis NCT07799116Phase 1, Phase 28 sites๐Ÿ“ Badalona๐Ÿ“ Santiago de Compostela๐Ÿ“ Pamplona Instituto de Investigaciรณn Sanitaria de la Fundaciรณn Jimรฉneโ€ฆ ยท Tests: TranspoCART19 Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children NCT06904729Phase 31 site๐Ÿ“ Guangzhou Guangzhou Women and Children's Medical Center ยท Tests: Low-dose CAR-T cells group, High-dose CAR-T cells group A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 NCT07403188n/a1 site๐Ÿ“ Denver Kyverna Therapeutics ยท Tests: KYV-101 Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus NCT06585514Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: CD19 CAR-T cells A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721Phase 11 site๐Ÿ“ Hefei China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy